Novo Nordisk Logo

Novo Nordisk

Develops treatments for serious chronic diseases like diabetes, obesity, and hemophilia.

NOVO | CO

Overview

Corporate Details

ISIN(s):
DK0062498333 (+1 more)
LEI:
549300DAQ1CVT6CXN342
Country:
Denmark
Address:
Novo Alle 1, 2880 Bagsværd

Description

Novo Nordisk is a global healthcare company dedicated to developing treatments for serious chronic diseases. With over a century of innovation, it is a world leader in diabetes care, providing a comprehensive portfolio of insulin products and GLP-1 receptor agonists. Leveraging its expertise in metabolic conditions, the company has also become a prominent force in obesity management. Novo Nordisk's therapeutic focus extends to other serious chronic conditions, including rare bleeding disorders like hemophilia and growth hormone-related disorders.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-03-10 11:23 English HTML 9.4 KB
2025-03-10 11:23 English PDF 99.0 KB
2025-02-27 16:58
FORM 6-K
English ZIP 5.5 MB
2025-02-10 16:09
IRANNOTICE
English ZIP 6.8 KB
2025-02-07 14:27
FORM 6-K
English ZIP 211.8 KB
2025-02-07 13:54 English HTML 18.2 KB
2025-02-07 13:54 English PDF 148.0 KB
2025-02-06 13:36
FORM 6-K
English ZIP 227.1 KB
2025-02-06 10:12 English HTML 259.4 KB
2025-02-06 10:12 English PDF 401.0 KB
2025-02-05 13:18
6-K
English ZIP 1.3 MB
2025-02-05 13:11
6-K
English ZIP 6.8 KB
2025-02-05 13:04
20-F
English ZIP 249.0 MB
2025-02-05 12:09
6-K
English ZIP 5.9 MB
2025-02-05 07:30 English HTML 14.0 KB

Automate Your Workflow. Get a real-time feed of all Novo Nordisk filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Novo Nordisk

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Novo Nordisk via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advicenne Logo
A specialty pharmaceutical company developing treatments for rare renal diseases.
France
ALDVI
AegirBio AB Logo
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
Sweden
AEGIR
Aelis Farma Logo
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Clinical-stage company developing therapeutic applications for botulinum toxins.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
Japan
2927
AGENUS INC Logo
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
United States of America
AGIO
AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo
Develops and markets medicines, focusing on respiratory and cardiovascular treatments.
South Korea
001540
Akari Therapeutics Plc Logo
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
United States of America
AKBA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.